Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica|October 3, 2015
Improvement of seminal quality and sexual function of men with oligoasthenoteratozoospermia syndrome following supplementation with L-arginine and Pycnogenol®Yoshitomo Kobori, Keisuke Suzuki, Toshiyuki Iwahata, et al.
Hinyokika Kiyo. Acta Urologica Japonica|February 26, 2004
[Clinical study of surgical site infection following portless endoscopic urological surgery (PLES)]Manabu Tadokoro, Hitoshi Masuda, Tetsuo Okuno, et al.
Prostate International|January 11, 2021
Efficacy and safety of apalutamide in Japanese patients with nonmetastatic castration-resistant prostate cancer: a subgroup analysis of a randomized, double-blind, placebo-controlled, Phase-3 studyHiroji Uemura, Takefumi Satoh, Hideyasu Tsumura, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|September 30, 2015
[SUCCESSFUL INGUINAL ORCHIECTOMY IN A PATIENT WITH A PAINFUL METASTATIC SPERMATIC CORD TUMOR: A CASE REPORT]Takeshi Shin, Gaku Arai, Toshiyuki Iwahata, et al.
Hinyokika Kiyo. Acta Urologica Japonica|May 6, 2003
[A case of fibroepithelial ureteral polyp in an adult patient]Shuichiro Kobayashi, Masahito Suzuki, Kazutaka Saito, et al.
Cancer Immunology, Immunotherapy : CII|February 7, 2020
Mixed 20-peptide cancer vaccine in combination with docetaxel and dexamethasone for castration-resistant prostate cancer: a randomized phase II trialMasanori Noguchi, Gaku Arai, Shin Egawa, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|December 9, 2020
Apalutamide for metastatic, castration-sensitive prostate cancer in the Japanese population: A subgroup analysis of the randomized, double-blind, placebo-controlled phase 3 TITAN studyHirotsugu Uemura, Gaku Arai, Hiroji Uemura, et al.
Anticancer Research|September 12, 2013
Efficacy of combined androgen blockade with zoledronic acid treatment in prostate cancer with bone metastasis: the ZABTON-PC (zoledronic acid/androgen blockade trial on prostate cancer) studySatoru Ueno, Atsushi Mizokami, Takashi Fukagai, et al.
International Journal of Clinical Oncology|June 9, 2026
Volume-adjusted p2PSA-derived indices for predicting prostate cancer: the PROPHET studyMasaki Shiota, Yoshitaka Sekine, Shoji Tokunaga, et al.
Oncology Reports|November 17, 2020
A randomized phase III trial of personalized peptide vaccination for castration‑resistant prostate cancer progressing after docetaxelMasanori Noguchi, Kiyohide Fujimoto, Gaku Arai, et al.
Pageof 6